These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37059389)

  • 1. Cardiovascular Risk Factors and Adherence to Cardiovascular Protection Practice Guidelines in Adults With Type 1 Diabetes: A BETTER Registry Cross-sectional Analysis.
    Madar H; Lalanne-Mistrih ML; Lebbar M; Wu Z; Robitaille Y; Pelletier J; Grou C; Brazeau AS; Rabasa-Lhoret R
    Can J Diabetes; 2023 Aug; 47(6):473-481.e1. PubMed ID: 37059389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.
    Bai JW; Boulet G; Halpern EM; Lovblom LE; Eldelekli D; Keenan HA; Brent M; Paul N; Bril V; Cherney DZ; Weisman A; Perkins BA
    Cardiovasc Diabetol; 2016 Jan; 15():14. PubMed ID: 26809442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiodiabetology: newer pharmacologic strategies for reducing cardiovascular disease risks.
    Wong ND
    Can J Physiol Pharmacol; 2022 Oct; 100(10):956-967. PubMed ID: 35772176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Pressure Management in Adults With Type 2 Diabetes: Insights From the Diabetes Mellitus Status in Canada (DM-SCAN) Survey.
    Grenier J; Goodman SG; Leiter LA; Langer A; Teoh H; Bhatt DL; Cheng AYY; Tan MK; Ransom T; Connelly KA; Yan AT
    Can J Diabetes; 2018 Apr; 42(2):130-137. PubMed ID: 28552652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between Socioeconomic Status and Patient Experience With Type 1 Diabetes Management and Complications: Cross-sectional Analysis of a Cohort From Québec, Canada.
    Talbo MK; Katz A; Dostie M; Legault L; Brazeau AS
    Can J Diabetes; 2022 Aug; 46(6):569-577. PubMed ID: 35864032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycaemic control and cardiovascular risk factor management in patients with diabetes with and without coronary artery disease: insights from the diabetes mellitus status in Canada survey.
    Grenier J; Leiter LA; Langer A; Goldin L; Teoh H; Connelly KA; Cheng AYY; Tan MK; Fitchett D; McGuire DK; Goodman SG; Yan AT
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):277-284. PubMed ID: 29474711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of coronary artery calcium score and cardiovascular risk-stratification by European Society of Cardiology Guidelines and Steno Type 1 Risk Engine in statin-naïve adults with type 1 diabetes.
    Goh YA; Lan NSR; Linn K; Wood C; Gupta A; Yeap BB; Fegan PG
    J Diabetes Complications; 2023 Aug; 37(8):108557. PubMed ID: 37473636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring Clinical Care Among Adults With Diabetes Mellitus: Alignment With Recommended Statin and Sulfonylureas Treatment.
    Sanchez-Ramirez DC; Singer A; Kosowan L; Polimeni C
    Can J Diabetes; 2019 Oct; 43(7):498-503. PubMed ID: 31307912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-Related Differences in the Control of Cardiovascular Risk Factors in Primary Care for Elderly Patients With Type 2 Diabetes: A Cohort Study.
    Al-Salameh A; Bucher S; Bauduceau B; Benattar-Zibi L; Berrut G; Bertin P; Corruble E; Danchin N; Derumeaux G; Doucet J; Falissard B; Forette F; Hanon O; Ourabah R; Pasquier F; Pinget M; Ringa V; Becquemont L
    Can J Diabetes; 2018 Aug; 42(4):365-371.e2. PubMed ID: 29037572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada.
    Braga M; Casanova A; Teoh H; Dawson KC; Gerstein HC; Fitchett DH; Harris SB; Honos G; McFarlane PA; Steele A; Ur E; Yale JF; Langer A; Goodman SG; Leiter LA;
    Can J Cardiol; 2010; 26(6):297-302. PubMed ID: 20548975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiometabolic Risk Factors and Incident Cardiovascular Disease Events in Women vs Men With Type 1 Diabetes.
    Braffett BH; Bebu I; El Ghormli L; Cowie CC; Sivitz WI; Pop-Busui R; Larkin ME; Gubitosi-Klug RA; Nathan DM; Lachin JM; Dagogo-Jack S;
    JAMA Netw Open; 2022 Sep; 5(9):e2230710. PubMed ID: 36074461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population health impact of statin treatment in Canada.
    Hennessy DA; Tanuseputro P; Tuna M; Bennett C; Perez R; Shields M; Ko DT; Tu J; Manuel DG
    Health Rep; 2016 Jan; 27(1):20-8. PubMed ID: 26788719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional study evaluating cardiovascular risk and statin prescribing in the Canadian Primary Care Sentinel Surveillance Network database.
    Johnston IS; Miles B; Soos B; Garies S; Perez G; Queenan JA; Drummond N; Singer A
    BMC Prim Care; 2022 May; 23(1):128. PubMed ID: 35614391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
    Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes.
    Elam MB; Ginsberg HN; Lovato LC; Corson M; Largay J; Leiter LA; Lopez C; O'Connor PJ; Sweeney ME; Weiss D; Friedewald WT; Buse JB; Gerstein HC; Probstfield J; Grimm R; Ismail-Beigi F; Goff DC; Fleg JL; Rosenberg Y; Byington RP;
    JAMA Cardiol; 2017 Apr; 2(4):370-380. PubMed ID: 28030716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use in adults at high risk of cardiovascular disease mortality: cross-sectional analysis of baseline data from The Irish Longitudinal Study on Ageing (TILDA).
    Murphy C; Bennett K; Fahey T; Shelley E; Graham I; Kenny RA
    BMJ Open; 2015 Jul; 5(7):e008017. PubMed ID: 26169806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes.
    Morieri ML; Perrone V; Veronesi C; Degli Esposti L; Andretta M; Plebani M; Fadini GP; Vigili de Kreutzenberg S; Avogaro A
    Cardiovasc Diabetol; 2021 Jul; 20(1):144. PubMed ID: 34271920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.